Banglades - angol - DGDA (Directorate General of Drug Administration)

beximco pharmaceuticals ltd. - amitriptyline hydrochloride + chlordiazepoxide - tablet - 12.5 mg + 5 mg

Banglades - angol - DGDA (Directorate General of Drug Administration)

eskayef pharmaceuticals ltd. mirpur. - amitriptyline hydrochloride + chlordiazepoxide - tablet - 12.5 mg + 5 mg

Banglades - angol - DGDA (Directorate General of Drug Administration)

eskayef pharmaceuticals ltd., tongi,gazipur - amitriptyline hydrochloride + chlordiazepoxide - tablet - 12.5 mg + 5 mg

Banglades - angol - DGDA (Directorate General of Drug Administration)

opsonin pharma limited - amitriptyline hydrochloride + chlordiazepoxide - tablet - 12.5 mg + 5 mg

Banglades - angol - DGDA (Directorate General of Drug Administration)

square pharmaceuticals plc, pabna - amitriptyline hydrochloride + chlordiazepoxide - tablet - 12.5 mg + 5 mg

Banglades - angol - DGDA (Directorate General of Drug Administration)

ziska pharmaceuticals ltd. - amitriptyline hydrochloride + chlordiazepoxide - tablet - 12.5 mg + 5 mg

Egyesült Államok - angol - NLM (National Library of Medicine)

carilion materials management - desipramine hydrochloride (unii: 1y58do4my1) (desipramine - unii:tg537d343b) - desipramine hydrochloride 10 mg - desipramine hydrochloride tablets, usp are indicated for the treatment of depression. the use of maois intended to treat psychiatric disorders with desipramine hydrochloride or within 14 days of stopping treatment with desipramine hydrochloride is contraindicated because of an increased risk of serotonin syndrome. the use of desipramine hydrochloride within 14 days of stopping an maoi intended to treat psychiatric disorders is also contraindicated (see warnings and dosage and administration ). starting desipramine hydrochloride in a patient who is being treated with maois such as linezolid or intravenous methylene blue is also contraindicated because of an increased risk of serotonin syndrome (see warnings and dosage and administration ). desipramine hydrochloride is contraindicated in the acute recovery period following myocardial infarction. it should not be used in those who have shown prior hypersensitivity to the drug. cross-sensitivity between this and other dibenzazepines is a possibility.

Egyesült Államok - angol - NLM (National Library of Medicine)

winthrop u.s. - desipramine hydrochloride (unii: 1y58do4my1) (desipramine - unii:tg537d343b) - desipramine hydrochloride 10 mg - desipramine hydrochloride is indicated for the treatment of depression. the use of maois intended to treat psychiatric disorders with desipramine hydrochloride or within 14 days of stopping treatment with desipramine hydrochloride is contraindicated because of an increased risk of serotonin syndrome. the use of desipramine hydrochloride within 14 days of stopping an maoi intended to treat psychiatric disorders is also contraindicated (see warnings and dosage and administration). starting desipramine hydrochloride in a patient who is being treated with maois such as linezolid or intravenous methylene blue is also contraindicated because of an increased risk of serotonin syndrome (see warnings and dosage and administration). desipramine hydrochloride is contraindicated in the acute recovery period following myocardial infarction. it should not be used in those who have shown prior hypersensitivity to the drug. cross-sensitivity between this and other dibenzazepines is a possibility.

Egyesült Államok - angol - NLM (National Library of Medicine)

corepharma, llc - desipramine hydrochloride (unii: 1y58do4my1) (desipramine - unii:tg537d343b) - desipramine hydrochloride 10 mg - desipramine hydrochloride tablets, usp are indicated for the treatment of depression. the use of maois intended to treat psychiatric disorders with desipramine hydrochloride or within 14 days of stopping treatment with desipramine hydrochloride is contraindicated because of an increased risk of serotonin syndrome. the use of desipramine hydrochloride within 14 days of stopping an maoi intended to treat psychiatric disorders is also contraindicated (see warnings  and dosage and administration). starting desipramine hydrochloride in a patient who is being treated with maois such as linezolid or intravenous methylene blue is also contraindicated because of an increased risk of serotonin syndrome (see warnings  and dosage and administration). desipramine hydrochloride is contraindicated in the acute recovery period following myocardial infarction. it should not be used in those who have shown prior hypersensitivity to the drug. cross-sensitivity between this and other dibenzazepines is a possibility.

Egyesült Államok - angol - NLM (National Library of Medicine)

rebel distributors corp - desipramine hydrochloride (unii: 1y58do4my1) (desipramine - unii:tg537d343b) - desipramine hydrochloride 10 mg - desipramine hydrochloride tablets are indicated for the treatment of depression. desipramine hydrochloride should not be given in conjunction with, or within 2 weeks of, treatment with an mao inhibitor drug; hyperpyretic crises, severe convulsions, and death have occurred in patients taking mao inhibitors and tricyclic antidepressants. when desipramine hydrochloride is substituted for an mao inhibitor, at least 2 weeks should elapse between treatments. desipramine hydrochloride should then be started cautiously and should be increased gradually. desipramine hydrochloride is contraindicated in the acute recovery period following myocardial infarction. it should not be used in those who have shown prior hypersensitivity to the drug. cross-sensitivity between this and other dibenzazepines is a possibility. deaths may occur from overdosage with this class of drugs. higher case fatality rates have been reported with desipramine overdose compared to other tricyclic antidepressants. multiple drug ingestion (includin